RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Peptide Therapy in The Colony TX RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 promoted in vivo and in vitro angiogenesis. a Representative Download Scientific Diagram